Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells

Archives of Biochemistry and Biophysics

Volumn 410, Issue 1, 2003, Pages 177-185

  Gupta, Sanjay ^a   Hussain, Tajamul ^b   Mukhtar, Hasan ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Apoptosis; Cell cycle; Epigallocatechin 3 gallate; Green tea; Prostate cancer

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; EPIGALLOCATECHIN GALLATE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN; PROTEIN P18; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA; CARRIER PROTEINS; CATECHIN; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; G1 PHASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0037330474     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9861(02)00668-9     Document Type: Article

References (46)

1. Katiyar S.K., Mohan R.R., Agarwal R., Mukhtar H. Carcinogenesis. 18:1997;497-502.
2. Liao S., Umekita Y., Guo J., Kokontis J.M., Hiipakka R.A. Cancer Lett. 96:1995;239-243.
3. Hirose M., Mizoguchi Y., Yaono M., Tanaka H., Yamaguchi T., Shirai T. Cancer Lett. 112:1997;141-147.
4. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., Mukhtar H. J. Natl. Cancer Inst. 89:1997;1881-1886.
5. Hibasami H., Komiya T., Achiwa Y., Ohnishi K., Kojima T., Nakanishi K., Akashi K., Hara Y. Oncol. Rep. 5:1998;527-529.
6. Khafif A., Schantz S.P., al-Rawi M., Edelstein D., Sacks P.G. Head Neck. 20:1998;528-534.
7. Otsuka T., Ogo T., Eto T., Asano Y., Suganuma M., Niho Y. Life Sci. 63:1998;1397-1403.
8. Conney A.H., Lu Y., Lou Y., Xie J., Huang M. Proc. Soc. Exp. Biol. Med. 220:1999;229-233.
9. Mimoto J., Kiura K., Matsuo K., Yoshino T., Takata I., Ueoka H., Kataoka M., Harada M. Carcinogenesis. 21:2000;915-919.
10. Sartippour M.R., Heber D., Ma J., Lu Q., Go V.L., Nguyen M. Nutr. Cancer. 40:2001;149-156.
11. Gupta S., Ahmad N., Nieminen A.L., Mukhtar H. Toxicol. Appl. Pharmacol. 164:2000;82-90.
12. Paschka A.G., Butler R., Young C.Y. Cancer Lett. 130:1998;1-7.
13. Lyn-Cook B.D., Rogers T., Yan Y., Blann E.B., Kadlubar F.F., Hammons G.J. Nutr. Cancer. 35:1999;80-86.
14. Yang G.Y., Liao J., Kim K., Yurkow E.J., Yang C.S. Carcinogenesis. 19:1998;611-616.
15. Gupta S., Hastak K., Ahmad N., Lewin J.S., Mukhtar H. Proc. Natl. Acad. Sci. USA. 98:2001;10350-10355.
16. McDonald E.R. III, El-Deiry W.S. Int. J. Oncol. 16:2000;871-886.
17. Owa T., Yoshino H., Yoshimatsu K., Nagasu T. Curr. Med. Chem. 8:2001;1487-1503.
18. Sherr C.J. Science. 274:1996;1672-1677.
19. Sandhu C., Slingerland J. Cancer Detect. Prev. 24:2000;107-118.
20. Kastan M.B., Canman C.E., Leonard C.J. Cancer Metastasis Rev. 14:1995;3-15.
21. Dong Z., Ma W., Huang C., Yang C.S. Cancer Res. 57:1997;4414-4419.
22. Weisburger J.H., Rivenson A., Aliaga C., Reinhardt J., Kelloff G.J., Boone C.W., Steele V.E., Balentine D.A., Pittman B., Zang E. Proc. Soc. Exp. Biol. Med. 217:1998;104-108.
23. Tosetti F., Ferrari N., De Flora S., Albini A. FASEB J. 16:2002;2-14.
24. Berger S.J., Gupta S., Belfi C.A., Gosky D.M., Mukhtar H. Biochem. Biophys. Res. Commun. 288:2001;101-105.
25. Chung J.Y., Park J.O., Phyu H., Dong Z., Yang C.S. FASEB J. 15:2001;2022-2024.
26. Chen Z.P., Schell J.B., Ho C.T., Chen K.Y. Cancer Lett. 129:1998;173-179.
27. Ahmad N., Gupta S., Mukhtar H. Arch. Biochem. Biophys. 376:2000;338-346.
28. Tang D.G., Porter A.T. Prostate. 32:1997;284-293.
29. Fisher D.E. Hematol. Oncol. Clin. North Am. 15:2001;931-956.
30. Kanduc D., Mittelman A., Serpico R., Sinigaglia E., Sinha A.A., Natale C., Santacroce R., Di Corcia M.G., Lucchese A., Dini L., Pani P., Santacroce S., Simone S., Bucci R., Farber E. Int. J. Oncol. 21:2002;165-170.
31. Ferreira C.G., Epping M., Kruyt F.A., Giaccone G. Clin. Cancer Res. 8:2002;2024-2034.
32. Penn L.Z. Curr. Opin. Invest. Drugs. 2:2001;684-692.
33. Molinari M. Cell Prolif. 33:2000;261-274.
34. Stewart Z.A., Pietenpol J.A. Chem. Res. Toxicol. 14:2001;243-263.
35. Jones S.M., Kazlauskas A. Oncogene. 19:2000;5558-5567.
36. Zwicker J., Muller R. Prog. Cell Cycle Res. 1:1995;91-99.
37. Agarwal M.L., Taylor W.R., Chernov M.V., Chernova O.B., Stark G.R. J. Biol. Chem. 273:1998;1-4.
38. Malkin D. J. Neurooncol. 51:2001;231-243.
39. Pavletich N.P. J. Mol. Biol. 287:1999;821-828.
40. Ortega S., Malumbres M., Barbacid M. Biochim. Biophys. Acta. 1602:2002;73-87.
41. Gartel A.L., Serfas M.S., Tyner A.L. Proc. Soc. Exp. Biol. Med. 213:1996;138-149.
42. Dotto G.P. Biochim. Biophys. Acta. 1471:2000;43-56.
43. Macri E., Loda M. Cancer Metastasis Rev. 17:1998-99;337-344.
44. Lloyd R.V., Erickson L.A., Jin L., Kulig E., Qian X., Cheville J.C., Scheithauer B.W. Am. J. Pathol. 154:1999;313-323.
45. Lukas J., Bartkova J., Rohde M., Strauss M., Bartek J. Mol. Cell Biol. 15:1995;2600-2611.
46. Bartkova J., Lukas J., Bartek J. Prog. Cell Cycle Res. 3:1997;211-220.